Prihlásiť sa Zaregistrujte sa zadarmo

Výnosy Q/Q spoločnosti Neovacs S.A

Aká je hodnota metriky Výnosy Q/Q spoločnosti Neovacs S.A?

Hodnota metriky Výnosy Q/Q spoločnosti Neovacs S.A. je 104.00%

Aká je definícia metriky Výnosy Q/Q?

Štvrťročný rast výnosov (Revenue Q/Q) z roku na rok je zvýšenie príjmov firmy v porovnaní s výsledkami v korešpondujúcom štvrťroku minulého roku a vyjadreného v percentách.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Výnosy Q/Q spoločností v sektore Health Care sektor na EURONEXT v porovnaní so spoločnosťou Neovacs S.A

Čomu sa venuje spoločnosť Neovacs S.A?

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.

Firmy s metrikou výnosy q/q podobnou spoločnosti Neovacs S.A



  • Hodnota metriky Výnosy Q/Q spoločnosti YPF je 103.49%
  • Hodnota metriky Výnosy Q/Q spoločnosti Shanghai Henlius Biotech Inc je 103.50%
  • Hodnota metriky Výnosy Q/Q spoločnosti Cullen Resources je 103.57%
  • Hodnota metriky Výnosy Q/Q spoločnosti OMV AG je 103.59%
  • Hodnota metriky Výnosy Q/Q spoločnosti Nikola je 103.87%
  • Hodnota metriky Výnosy Q/Q spoločnosti Elsight je 103.88%
  • Hodnota metriky Výnosy Q/Q spoločnosti Neovacs S.A je 104.00%
  • Hodnota metriky Výnosy Q/Q spoločnosti Sejal Glass je 104.02%
  • Hodnota metriky Výnosy Q/Q spoločnosti Sensus Healthcare Inc je 104.09%
  • Hodnota metriky Výnosy Q/Q spoločnosti Orion Oyj je 104.15%
  • Hodnota metriky Výnosy Q/Q spoločnosti Asensus Surgical Inc je 104.16%
  • Hodnota metriky Výnosy Q/Q spoločnosti Points.com Inc je 104.24%
  • Hodnota metriky Výnosy Q/Q spoločnosti Sigilon Therapeutics je 104.65%